HBV mutation literature information.


  [Monitoring by high-sensitivity HBV DNA assay during treatment in chronic hepatitis B e antigen negative patients].
 PMID: 29804376       2018       Zhonghua gan zang bing za zhi
Abstract: After treatment, the detection rate of the above mutation sites decreased, but C1653T, C1673T and G1899A were not detected.
Abstract: Patients C, B, C, B, and C were examined for C1673T, G1896, G1858, G1899A.


  Basal core promoter and precore mutations among hepatitis B virus circulating in Brazil and its association with severe forms of hepatic diseases.
 PMID: 28902288       2017       Memorias do Instituto Oswaldo Cruz
Result: BCP and PC mutations and forms of chronic HBV infection - Among the 129 patients in whom the HBV PC region was analysed, a high frequency of HBV strains with G1896A mutation (53/129, 41%) was detected, alone or in G1896A/G1899A double mutation, particularly in the subgroup with HBeAg-negative chronic hepatitis (39/85, 45.9%) (p = 0.03).
Table: G1899A


  Differential regulation of hepatitis B virus core protein expression and genome replication by a small upstream open reading frame and naturally occurring mutations in the precore region.
 PMID: 28260621       2017       Virology
Result: Comparison of alphalM0, F (alphalM0 with mutated precore ATG), and alphal in the same blot indicates that G1896A/G1899A were more effective than mutated precore ATG in augmenting core protein expression, although ol+36 did not show
Discussion: Among HBeAg-negative precore mutations tested, G1896A in conjunction with G1899A was more effective than mutated precore ATG at increasing core protein expression.
Discussion: Both the G1896A and G1899A mutations convert a U:G pair in stem I into a UA pair.


  Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co-infected Nigerians.
 PMID: 28376292       2017       Tropical medicine & international health
Result: Twenty patients (57%) had PC G1896A mutations and 12 (34%) had PC G1899A mutations.


  Phenotypic and Genotypic Shifts in Hepatitis B Virus in Treatment-Naive Patients, Taiwan, 2008-2012.
 PMID: 28418295       2017       Emerging infectious diseases
Abstract: Over time, we observed substantial decreases in the prevalence of HBV e antigen (HBeAg) and increasing prevalence of the precore G1899A mutation and HBV-DNA levels in HBeAg-positive patients.
Conclusion: On the other hand, prevalence of G1899A mutations increased from 2.5% to 17.4%.
Conclusion: Over the 5 years of this study, we found an increasing prevalence of G1899A mutations and an increasing concentration of serum HBV DNA in treatment-naive, HBeAg-positive patients.

Browser Board

 Co-occurred Entities




   Filtrator